Devalued and Distrusted : (Record no. 20347)

MARC details
000 -LEADER
fixed length control field 04296cam a2200733Ma 4500
001 - CONTROL NUMBER
control field ocn831464032
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230823095113.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 121010s2013 nju ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AZU
Language of cataloging eng
Description conventions pn
Transcribing agency AZU
Modifying agency OCLCO
-- CCO
-- IDEBK
-- E7B
-- GPM
-- OCLCF
-- YDXCP
-- RECBK
-- MHW
-- EBLCP
-- N$T
-- DG1
-- TEFOD
-- DEBSZ
-- UKDOC
-- LRU
-- GGVRL
-- OCLCQ
-- AU@
-- CDX
-- DEBBG
-- TEFOD
-- OCLCQ
-- COO
-- OCLCQ
-- NKT
-- AZK
019 ## -
-- 823389919
-- 829353805
-- 864914474
-- 880910023
-- 961488066
-- 962624123
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118487471
Qualifying information (pbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118487478
Qualifying information (pbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781283917421
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1283917424
Qualifying information (MyiLibrary)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118511251
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118511255
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118511299
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118511298
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118511329
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118511328
Qualifying information (electronic bk.)
028 01 - PUBLISHER NUMBER
Publisher number EB00063788
Source Recorded Books
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000050591439
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000051955577
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000052918221
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV040884467
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV041052577
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV041906704
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 397453892
029 1# - (OCLC)
OCLC library identifier DKDLA
System control number 820120-katalog:000600440
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 14976927
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043395679
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)831464032
Canceled/invalid control number (OCoLC)823389919
-- (OCoLC)829353805
-- (OCoLC)864914474
-- (OCoLC)880910023
-- (OCoLC)961488066
-- (OCoLC)962624123
037 ## - SOURCE OF ACQUISITION
Stock number 684D5251-34C3-4198-A03A-18F445996D72
Source of stock number/acquisition OverDrive, Inc.
Note http://www.overdrive.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9665.5
Item number .L36 2013eb
072 #7 - SUBJECT CATEGORY CODE
Subject category code BUS
Subject category code subdivision 070130
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.4/76151
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name LaMattina, John L.
245 10 - TITLE STATEMENT
Title Devalued and Distrusted :
Remainder of title Can the Pharmaceutical Industry Restore Its Broken Image? /
Statement of responsibility, etc John L. LaMattina, PhD.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, New Jersey :
Name of publisher, distributor, etc Wiley,
Date of publication, distribution, etc [2013]
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (ix, 125 pages)
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- data file
-- rda
500 ## - GENERAL NOTE
General note Includes index.
500 ## - GENERAL NOTE
General note Machine generated contents note: Introduction Part 1. "The 4 secrets that drug companies don't want you to know" part 2. What has happened to R & D productivity? a. impact of mergers b. impact of FDA c. impact of payers Part 3. Challenges in key therapeutic areas for improving health a. cancer b. diseases of the brain c. cardiovascular disease d. diabetes e. bacterial Infections part 4. Improving R & D output a. view of others b. personal vision part 5. Restoring the pharma image part 6. Final thoughts.
588 0# -
-- Print version record.
520 ## - SUMMARY, ETC.
Summary, etc "While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R & D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"--
-- Provided by publisher.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. The four secrets the drug companies don't want you to know -- 2. What has happened to R & D productivity? -- 3. Key therapeutic areas for improving health -- 4. Improving R & D output -- 5. Restoring pharma's image -- 6. Final thoughts.
526 ## - STUDY PROGRAM INFORMATION NOTE
Department Public Health
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
General subdivision Corrupt practices.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medical.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
General subdivision Corrupt practices.
Source of heading or term fast
-- (OCoLC)fst01060133
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Main entry heading LaMattina, John L.
Title Devalued and distrusted.
Place, publisher, and date of publication Hoboken, New Jersey : John Wiley & Sons, Inc., [2013]
International Standard Book Number 9781118487471
Record control number (DLC) 2012032915
-- (OCoLC)811597120
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1002/9781118511329">http://dx.doi.org/10.1002/9781118511329</a>
Public note Wiley Online Library
994 ## -
-- 92
-- DG1

No items available.